Quality in Sport
Cure8 research brief
Why This Matters
IBD-U means no clear Crohn’s or ulcerative colitis diagnosis yet — that uncertainty can affect treatment decisions and follow-up. The review highlights tests that may help clarify diagnosis and stresses that many patients (especially kids) are later reclassified.
Who Should Pay Attention
Clinicians managing IBD, pediatric patients and their caregivers, and newly diagnosed people with unclear IBD classification.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This narrative review summarizes challenges in diagnosing inflammatory bowel disease unclassified (IBD-U), compares it with Crohn’s disease and ulcerative colitis, and reviews diagnostic tools including ileocolonoscopy, magnetic resonance enterography, capsule endoscopy, and selected serological/biomarker tests.
The authors emphasize that IBD-U is a diagnosis of exclusion that often requires repeated multidisciplinary assessment and long-term follow-up; disease reclassification is particularly common in children.
Keep In Mind
This article is a narrative review (abstract level provided). It synthesizes recent literature and guidelines through 2026 but does not present new trial results; conclusions reflect the state of evidence and expert interpretation rather than a single study finding.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationQuality in Sport
PublisherUniwersytet Mikolaja Kopernika/Nicolaus Copernicus University
AuthorsAnna Zyskowska, Piotr Ziajka, Agnieszka Zwolińska +7 more
Study typeJournal Article
Indexed viaCrossref
Source typeResearch paper
PublishedAug 23, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Association of serological markers with endoscopic mucosal healing and disease activity in patients with inflammatory bowel disease: a retrospective study
Blood markers that correlate with endoscopic healing could help track inflammation noninvasively and may reduce the frequency of endoscopy if validated. For people with IBD, better blood-based tools could make monitoring...
“The role of red cell distribution width in inflammatory bowel disease evaluation: a comprehensive systematic review and meta-analysis”
RDW is part of a routine complete blood count and, if reliably associated with IBD activity, could offer a low-cost, widely available adjunctive biomarker for detecting disease and monitoring activity.
"The role of red cell distribution width in inflammatory bowel disease evaluation: a comprehensive systematic review and meta-analysis".
The review suggests RDW, an inexpensive and widely available blood test parameter, is higher in IBD and correlates with disease activity—meaning it might help clinicians monitor disease alongside other tests.